BAY 94 ‐9027, a PEGylated recombinant factor VIII, exhibits a prolonged half‐life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies

Haemophilia, EarlyView.

Source: Haemophilia - July 2, 2018 Category: Hematology Authors: A. Shah , T. Coyle , S. Lalezari , K. Fischer , B. Kohlstaedde , H. Delesen , S. Radke , L. A. Michaels Source Type: research